Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Bubalo

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Transplantation and Cellular Therapy|January 7, 2023
A Weighty Decision: Worth the wait?Joseph Bubalo
Current Hematologic Malignancy Reports|February 7, 2018
Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on DeliriumJoseph Bubalo
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 26, 2020
Capsule-related dysphagia and the use of netupitant/palonosetron (Akynzeo™) capsules - A report of two cases and a solutionKevin Behbahany, Joseph Bubalo
Cancer Management and Research|September 18, 2014
Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapyMary Lou Affronti, Joseph Bubalo
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2019
Instilling value, quality, and safety through hematology and oncology stewardshipClement Chung, Sara Kim, Joseph Bubalo
Drugs|June 23, 2021
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for PharmacistsJeffrey Gilreath, Mimi Lo, Joseph Bubalo
The Annals of Pharmacotherapy|February 27, 2025
Retrospective Analysis of Tacrolimus Levels: The First 56 Days Following Allogeneic Hematopoietic Stem Cell Transplant and Patient OutcomesKateryna Kovalenko, Joseph Bubalo, Jennifer Saultz, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2022
Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant PatientsShiela McCollam, James S Lewis, Joseph Bubalo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
Bone Marrow Transplantation|February 21, 2018
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT)Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|January 7, 2023
A Weighty Decision: Worth the wait?Joseph Bubalo
Current Hematologic Malignancy Reports|February 7, 2018
Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on DeliriumJoseph Bubalo
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 26, 2020
Capsule-related dysphagia and the use of netupitant/palonosetron (Akynzeo™) capsules - A report of two cases and a solutionKevin Behbahany, Joseph Bubalo
Cancer Management and Research|September 18, 2014
Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapyMary Lou Affronti, Joseph Bubalo
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2019
Instilling value, quality, and safety through hematology and oncology stewardshipClement Chung, Sara Kim, Joseph Bubalo
Drugs|June 23, 2021
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for PharmacistsJeffrey Gilreath, Mimi Lo, Joseph Bubalo
The Annals of Pharmacotherapy|February 27, 2025
Retrospective Analysis of Tacrolimus Levels: The First 56 Days Following Allogeneic Hematopoietic Stem Cell Transplant and Patient OutcomesKateryna Kovalenko, Joseph Bubalo, Jennifer Saultz, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2022
Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant PatientsShiela McCollam, James S Lewis, Joseph Bubalo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
Bone Marrow Transplantation|February 21, 2018
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT)Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, et al.
Pageof 3